RESUMO
The purpose of this research is to develop an innovative software framework with AI capabilities to predict the quality of automobiles at the end of the production line. By utilizing machine learning techniques, this framework aims to prevent defective vehicles from reaching customers, thus enhancing production efficiency, reducing costs, and shortening the manufacturing time of automobiles. The principal results demonstrate that the predictive quality inspection framework significantly improves defect detection and supports personalized road tests. The major conclusions indicate that integrating AI into quality control processes offers a sustainable, long-term solution for continuous improvement in automotive manufacturing, ultimately increasing overall production efficiency. The economic benefit of our solution is significant. Currently, a final test drive takes 10-30 min, depending on the car model. If 200,000-300,000 cars are produced annually and our data prediction of quality saves 10 percent of test drives with test drivers, this represents a minimum annual saving of 200,000 production minutes.
RESUMO
Serum PCB congener concentrations were measured in 602 adults living near a PCB pollution source in eastern Slovakia. We created isoconcentration maps for 21 PCB congeners by geocoding each participant's place of residence and kriging. Concentrations of PCB congeners were inversely associated with the distance of the participants' residence from the source of pollution. Congener-specific risk factors were derived, particularly for PCBs 52 and 153. We observed that the spatial distribution of serum concentrations was influenced by micro-climatic parameters and physicochemical properties of the congeners. PCB congener profiles strongly correlated with that of the PCB commercial product Delor 106, which was manufactured in the region. The isoconcentration maps indicate that the zones with the highest predicted congener concentration have a mean area of approximately 235.75±188.56km2 and the mean enrichment of concentration of congeners in serum in these zones is about 5.12±1.36. We estimate that depending on congener approximately 23,457±18,762 individuals with PCB concentrations exceeding health-based guidance values live in these zones.